Date | Name | Shares | Transaction | Value |
Mar 21, 2025
| Laura J. Schumacher Director |
11,542
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
3,052,859.00
|
Mar 21, 2025
| Catherine B. Reynolds Director |
6,732
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
1,780,614.00
|
Mar 21, 2025
| C. Howard Nye Director |
6,147
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
1,625,881.50
|
Mar 21, 2025
| John G. Stratton Director |
7,790
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
2,060,455.00
|
Mar 21, 2025
| Charles W. Hooper Director |
979
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
258,945.50
|
Mar 21, 2025
| Cecil D. Haney Director |
2,803
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
741,393.50
|
Mar 21, 2025
| Mark M. Malcolm Director |
10,075
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
2,664,837.50
|
Mar 21, 2025
| Rudy F. de Leon Director |
5,428
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $264.5 per share |
1,435,706.00
|
Mar 13, 2025
| Marguerite Amy Gilliland Senior Vice President |
72,754
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $223.93 per share |
16,291,803.22
|
Mar 13, 2025
| Marguerite Amy Gilliland Senior Vice President |
48,014
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $272.08 per share |
13,063,649.12
|
Mar 13, 2025
| Marguerite Amy Gilliland Senior Vice President |
45,192
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $272.41 per share |
12,310,752.72
|
Mar 13, 2025
| Marguerite Amy Gilliland Senior Vice President |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 7, 2025
| Phebe N. Novakovic Chairman and CEO; Director |
788,792
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $253.95 per share |
200,313,728.40
|
Mar 7, 2025
| Shane Berg Senior Vice President |
20,600
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Phebe N. Novakovic Chairman and CEO; Director |
769,607
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $263.48 per share |
202,776,052.36
|
Mar 7, 2025
| Phebe N. Novakovic Chairman and CEO; Director |
809,843
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Laura J. Schumacher Director |
1,370
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Rudy F. de Leon Director |
1,370
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| John G. Stratton Director |
1,370
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Catherine B. Reynolds Director |
1,370
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|